Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome

Journal of Allergy and Clinical Immunology

Volumn 128, Issue 6, 2011, Pages

  Ko, Tai Ming ^a,b   Chung, Wen Hung ^c   Wei, Chun Yu ^b   Shih, Han Yu ^a,b   Chen, Jung Kuei ^b   Lin, Chia Hsien ^b   Chen, Yuan Tsong ^a,b   Hung, Shuen Iu ^b,d  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Drug hypersensitivity; HLA; Stevens Johnson syndrome; T cell receptor; third complementarity determining region; toxic epidermal necrolysis

Indexed keywords

CARBAMAZEPINE; GRANULYSIN; HLA B ANTIGEN; T LYMPHOCYTE RECEPTOR;

ANTIGEN PRESENTING CELL; ARTICLE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CONTROLLED STUDY; CROSS REACTION; DISEASE PREDISPOSITION; DRUG CYTOTOXICITY; DRUG EXPOSURE; HLA SYSTEM; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; IN VITRO STUDY; LYMPHOCYTE CULTURE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; STEVENS JOHNSON SYNDROME;

EID: 82555166978     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.08.013     Document Type: Article

References (41)

1. J.C. Roujeau, J.P. Kelly, L. Naldi, B. Rzany, R.S. Stern, and T. Anderson Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis N Engl J Med 333 1995 1600 1607
2. Y. Wu, J. Farrell, M. Pirmohamed, B.K. Park, and D.J. Naisbitt Generation and characterization of antigen-specific CD4+, CD8+, and CD4+CD8+ T-cell clones from patients with carbamazepine hypersensitivity J Allergy Clin Immunol 119 2007 973 981 (Pubitemid 46527813)
3. J.C. Roujeau Immune mechanisms in drug allergy Allergol Int 55 2006 27 33
4. W.J. Pichler, A. Beeler, M. Keller, M. Lerch, S. Posadas, and D. Schmid Pharmacological interaction of drugs with immune receptors: the p-i concept Allergol Int 55 2006 17 25
5. W.H. Chung, S.I. Hung, J.Y. Yang, S.C. Su, S.P. Huang, and C.Y. Wei Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis Nat Med 14 2008 1343 1350
6. A. Nassif, A. Bensussan, L. Boumsell, A. Deniaud, H. Moslehi, and P. Wolkenstein Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells J Allergy Clin Immunol 114 2004 1209 1215 (Pubitemid 39469167)
7. E. Morel, S. Escamochero, R. Cabanas, R. Diaz, A. Fiandor, and T. Bellon CD94/NKG2C is a killer effector molecule in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis J Allergy Clin Immunol 125 2010 703 710 e1-10
8. C.W. Yang, S.I. Hung, C.G. Juo, Y.P. Lin, W.H. Fang, and I.H. Lu HLA-B1502-bound peptides: implications for the pathogenesis of carbamazepine-induced Stevens-Johnson syndrome J Allergy Clin Immunol 120 2007 870 877
9. A.K. Daly, P.T. Donaldson, P. Bhatnagar, Y. Shen, I. Pe'er, and A. Floratos HLA-B5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin Nat Genet 41 2009 816 819
10. S.I. Hung, W.H. Chung, L.B. Liou, C.C. Chu, M. Lin, and H.P. Huang HLA-B5801 allele as a genetic marker for severe cutaneous adverse reactions caused by allopurinol Proc Natl Acad Sci U S A 102 2005 4134 4139 (Pubitemid 40388568)
11. W.H. Chung, S.I. Hung, H.S. Hong, M.S. Hsih, L.C. Yang, and H.C. Ho Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 2004 486
12. S. Mallal, D. Nolan, C. Witt, G. Masel, A.M. Martin, and C. Moore Association between presence of HLA-B5701, HLA-DR7, and HLA-DQ3 and hypersensitivity to HIV-1 reverse-transcriptase inhibitor abacavir Lancet 359 2002 727 732 (Pubitemid 34215071)
13. J.B. Singer, S. Lewitzky, E. Leroy, F. Yang, X. Zhao, and L. Klickstein A genome-wide study identifies HLA alleles associated with lumiracoxib-related liver injury Nat Genet 42 2010 711 714
14. P. Chen, J.J. Lin, C.S. Lu, C.T. Ong, P.F. Hsieh, and C.C. Yang Carbamazepine-induced toxic effects and HLA-B1502 screening in Taiwan N Engl J Med 364 2011 1126 1133
15. C. Locharernkul, J. Loplumlert, C. Limotai, W. Korkij, T. Desudchit, and S. Tongkobpetch Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated with HLA-B1502 allele in Thai population Epilepsia 49 2008 2087 2091
16. T.Y. Mehta, L.M. Prajapati, B. Mittal, C.G. Joshi, J.J. Sheth, and D.B. Patel Association of HLA-B1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians Indian J Dermatol Venereol Leprol 75 2009 579 582
17. C.B. Man, P. Kwan, L. Baum, E. Yu, K.M. Lau, and A.S. Cheng Association between HLA-B1502 allele and antiepileptic drug-induced cutaneous reactions in Han Chinese Epilepsia 48 2007 1015 1018 (Pubitemid 46763406)
18. A. Hermansson, D.F. Ketelhuth, D. Strodthoff, M. Wurm, E.M. Hansson, and A. Nicoletti Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis J Exp Med 207 2010 1081 1093
19. A.M. Risitano, J.P. Maciejewski, S. Green, M. Plasilova, W. Zeng, and N.S. Young In-vivo dominant immune responses in aplastic anaemia: molecular tracking of putatively pathogenetic T-cell clones by TCR beta-CDR3 sequencing Lancet 364 2004 355 364 (Pubitemid 38970012)
20. Z. Hovhannisyan, A. Weiss, A. Martin, M. Wiesner, S. Tollefsen, and K. Yoshida The role of HLA-DQ8 beta57 polymorphism in the anti-gluten T-cell response in coeliac disease Nature 456 2008 534 538 (Pubitemid 352759011)
21. E. Padovan, G. Casorati, P. Dellabona, S. Meyer, M. Brockhaus, and A. Lanzavecchia Expression of two T cell receptor alpha chains: dual receptor T cells Science 262 1993 422 424 (Pubitemid 23353384)
22. N.N. Hunder, H. Wallen, J. Cao, D.W. Hendricks, J.Z. Reilly, and R. Rodmyre Treatment of metastatic melanoma with autologous CD4+ T cells against NY-ESO-1 N Engl J Med 358 2008 2698 2703 (Pubitemid 351860862)
23. S.I. Hung, W.H. Chung, Z.S. Liu, C.H. Chen, M.S. Hsih, and R.C. Hui Common risk allele in aromatic antiepileptic-drug induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Han Chinese Pharmacogenomics 11 2010 349 356
24. Y. Wu, J.P. Sanderson, J. Farrell, N.S. Drummond, A. Hanson, and E. Bowkett Activation of T cells by carbamazepine and carbamazepine metabolites J Allergy Clin Immunol 118 2006 233 241 (Pubitemid 43964854)
25. R.G. Beran Cross-reactive skin eruption with both carbamazepine and oxcarbazepine Epilepsia 34 1993 163 165 (Pubitemid 23045084)
26. P.B. Ferrell Jr., and H.L. McLeod Carbamazepine, HLA-B1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations Pharmacogenomics 9 2008 1543 1546
27. D. Chessman, L. Kostenko, T. Lethborg, A.W. Purcell, N.A. Williamson, and Z. Chen Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity Immunity 28 2008 822 832 (Pubitemid 351784513)
28. J.R. Currier, and M.A. Robinson Spectratype/immunoscope analysis of the expressed TCR repertoire Curr Protoc Immunol 2001 Chapter 10:Unit 10.28
29. S. Ochsenreither, A. Fusi, A. Busse, D. Nagorsen, D. Schrama, and J. Becker Relative quantification of TCR Vbeta-chain families by real time PCR for identification of clonal T-cell populations J Transl Med 6 2008 34
30. J. Hallmayer, J. Faraco, L. Lin, S. Hesselson, J. Winkelmann, and M. Kawashima Narcolepsy is strongly associated with the T-cell receptor alpha locus Nat Genet 41 2009 708 711
31. D.L. Mueller Mechanisms maintaining peripheral tolerance Nat Immunol 11 2010 21 27
32. P. Bousso, A. Casrouge, J.D. Altman, M. Haury, J. Kanellopoulos, and J.P. Abastado Individual variations in the murine T cell response to a specific peptide reflect variability in naive repertoires Immunity 9 1998 169 178 (Pubitemid 28400030)
33. L. Guglielmi, P. Guglielmi, and P. Demoly Drug hypersensitivity: epidemiology and risk factors Curr Pharm Des 12 2006 3309 3312 (Pubitemid 44364119)
34. F.J. Aceves-Avila, and V. Benites-Godinez Drug allergies may be more frequent in systemic lupus erythematosus than in rheumatoid arthritis J Clin Rheumatol 14 2008 261 263
35. L.J. Hirsch, H. Arif, E.A. Nahm, R. Buchsbaum, S.R. Resor Jr., and C.W. Bazil Cross-sensitivity of skin rashes with antiepileptic drug use Neurology 71 2008 1527 1534
36. T.W. May, E. Korn-Merker, and B. Rambeck Clinical pharmacokinetics of oxcarbazepine Clin Pharmacokinet 42 2003 1023 1042 (Pubitemid 37186675)
37. E.A. Dogan, B.E. Usta, R. Bilgen, Y. Senol, and B. Aktekin Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy Epilepsy Behav 13 2008 156 161
38. Y. Buggy, D. Layton, C. Fogg, and S.A. Shakir Safety profile of oxcarbazepine: results from a prescription-event monitoring study Epilepsia 51 2010 818 829
39. H. Le Louet, L. Thomas, and S. Babai DRESS: is oxcarbazepine safer than carbamazepine? An analysis of the French Pharmacovigilance database Eur J Neurol 15 2008 e43
40. J.R. Currier, and M.A. Robinson Spectratype/immunoscope analysis of the expressed TCR repertoire Curr Protoc Immunol 2001 Chapter 10:Unit 10.28
41. W.H. Chung, S.I. Hung, H.S. Hong, M.S. Hsih, L.C. Yang, and H.C. Ho Medical genetics: a marker for Stevens-Johnson syndrome Nature 428 2004 486